Loading...
•
Dec 31, 2022
Quaker Chemical Q4 2022 Earnings Report
Reported an 8% increase in net sales driven by higher selling prices and a net loss due to a $93.0 million impairment charge, with non-GAAP earnings per share of $1.39 and adjusted EBITDA of $67.9 million.
Key Takeaways
Quaker Houghton's Q4 2022 net sales increased by 8% to $484.8 million compared to Q4 2021, driven by higher selling prices. The company reported a net loss of $76.0 million, or $4.24 per diluted share, which includes a $93.0 million impairment charge. Non-GAAP net income was $25.0 million, or $1.39 per diluted share, and adjusted EBITDA increased by 12% to $67.9 million.
Net sales increased 8% compared to Q4 2021, reaching $484.8 million.
Net loss of $76.0 million, or $4.24 per diluted share, includes a $93.0 million impairment charge.
Non-GAAP net income was $25.0 million, or $1.39 per diluted share.
Adjusted EBITDA increased 12% to $67.9 million compared to Q4 2021.
Revenue by Geographic Location
Forward Guidance
The company expects to deliver further progress in 2023 through pricing and cost actions.
Positive Outlook
- Margin recovery remains a top priority.
- Further progress expected in 2023 through pricing actions.
- Further progress expected in 2023 through cost actions.
- Committed to advancing strategic initiatives.
- Strong foundation to drive continued long-term growth and value.
Challenges Ahead
- Significant macroeconomic challenges.
- Significant raw material challenges.
- Significant market challenges.
- Softer market conditions.
- Ongoing war in Ukraine.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...